[1] RUBIN D T, ANANTHAKRISHNAN A N, SIEGEL C A, et al. ACG clinical guideline: ulcerative colitis in adults[J]. Am J Gastroenterol, 2019, 114(3): 384-413. doi:  10.14309/ajg.0000000000000152
[2] MOLLER F T, ANDERSEN V, WOHLFAHRT J, et al. Familial risk of inflammatory bowel disease: a population-based cohort study 1977-2011[J]. Am J Gastroenterol, 2015, 110(4): 564-571. doi:  10.1038/ajg.2015.50
[3] 邵雪庆. 治疗慢性结肠炎新药-愈肠颗粒的制剂及药效学研究[D]. 上海: 海军军医大学, 2018.
[4] RU J L, LI P, WANG J N, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines[J]. J Cheminform, 2014, 6: 13. doi:  10.1186/1758-2946-6-13
[5] YE H, YE L, KANG H, et al. HIT: linking herbal active ingredients to targets[J]. Nucleic Acids Res, 2011, 39(Database issue): D1055-D1059.
[6] YAN D Y, ZHENG G H, WANG C C, et al. HIT 2.0: an enhanced platform for Herbal Ingredients’ Targets[J]. Nucleic Acids Res, 2022, 50(D1): D1238-D1243. doi:  10.1093/nar/gkab1011
[7] 杨洁, 张明明, 于道远, 等. 代红雨教授治疗炎症性肠病经验浅谈[J]. 四川中医, 2023, 41(11): 1-3. doi:  10.3969/j.issn.1000-3649.2023.11.sczy202311001
[8] 雷露, 吕沛然, 张宁, 等. 中医治疗炎症性肠病机制的研究进展[J]. 中医药学报, 2024, 52(2): 116-121.
[9] 凌海慧, 梁棻, 刘蓉, 等. 中医药保护肠黏膜屏障治疗炎症性肠病的研究进展[J]. 天津中医药, 2018, 35(9): 718-720.
[10] 秦广宁, 刘耀远, 高宁, 等. 张伯礼基于 “湿浊痰饮类病” 学说分期论治极早发型炎症性肠病经验[J]. 中医杂志, 2023, 64(22): 2282-2286.
[11] WUSHOUER X, AXIMUJIANG K, KADEER N, et al. Effect of huankuile on colon injury in rats with ulcerative colitis by reducing TNF-α and MMP9[J]. Eur J Med Res, 2024, 29(1): 102. doi:  10.1186/s40001-024-01695-w
[12] WANG X J, XIE X T, LI Y Y, et al. Quercetin ameliorates ulcerative colitis by activating aryl hydrocarbon receptor to improve intestinal barrier integrity[J]. Phytother Res, 2024, 38(1): 253-264. doi:  10.1002/ptr.8027
[13] ZHOU H F, YANG C, LI J Y, et al. Quercetin serves as the major component of Xiang-Lian Pill to ameliorate ulcerative colitis via tipping the balance of STAT1/PPARγ and dictating the alternative activation of macrophage[J]. J Ethnopharmacol, 2023, 313: 116557. doi:  10.1016/j.jep.2023.116557
[14] KIM W S, SONG H Y, HAN J M, et al. GLM, a novel luteolin derivative, attenuates inflammatory responses in dendritic cells: Therapeutic potential against ulcerative colitis[J]. Biochem Biophys Res Commun, 2019, 518(1): 87-93. doi:  10.1016/j.bbrc.2019.08.012
[15] LI B L, DU P L, DU Y, et al. Luteolin alleviates inflammation and modulates gut microbiota in ulcerative colitis rats[J]. Life Sci, 2021, 269: 119008. doi:  10.1016/j.lfs.2020.119008
[16] LI B L, ZHAO D Y, DU P L, et al. Luteolin alleviates ulcerative colitis through SHP-1/STAT3 pathway[J]. Inflamm Res, 2021, 70(6): 705-717. doi:  10.1007/s00011-021-01468-9
[17] XUE L, JIN X, JI T, et al. Luteolin ameliorates DSS-induced colitis in mice via suppressing macrophage activation and chemotaxis[J]. Int Immunopharmacol, 2023, 124(pt b): 110996.
[18] XIE X Q, ZHAO M, HUANG S W, et al. Luteolin alleviates ulcerative colitis by restoring the balance of NCR−ILC3/NCR+ILC3 to repairing impaired intestinal barrier[J]. Int Immunopharmacol, 2022, 112: 109251. doi:  10.1016/j.intimp.2022.109251
[19] LI B, GUO Y, JIA X, et al. Luteolin alleviates ulcerative colitis in rats via regulating immune response, oxidative stress, and metabolic profiling[J]. Open Med(Wars), 2023, 18(1): 20230785. doi:  10.1515/med-2023-0785
[20] VUKELIĆ I, DETEL D, BATIČIĆ L, et al. Luteolin ameliorates experimental colitis in mice through ERK-mediated suppression of inflammation, apoptosis and autophagy[J]. Food Chem Toxicol, 2020, 145: 111680. doi:  10.1016/j.fct.2020.111680
[21] DING K, TAN Y Y, DING Y, et al. β-Sitosterol improves experimental colitis in mice with a target against pathogenic bacteria[J]. J Cell Biochem, 2019, 120(4): 5687-5694. doi:  10.1002/jcb.27853
[22] ZHANG D, GE F, JI J, et al. β-sitosterol alleviates dextran sulfate sodium-induced experimental colitis via inhibition of NLRP3/Caspase-1/GSDMD-mediated pyroptosis[J]. Front Pharmacol, 2023, 14: 1218477. doi:  10.3389/fphar.2023.1218477
[23] QU Y F, LI X Y, XU F Y, et al. Kaempferol alleviates murine experimental colitis by restoring gut microbiota and inhibiting the LPS-TLR4-NF-κB axis[J]. Front Immunol, 2021, 12: 679897. doi:  10.3389/fimmu.2021.679897
[24] PARK M Y, JI G E, SUNG M K. Dietary kaempferol suppresses inflammation of dextran sulfate sodium-induced colitis in mice[J]. Dig Dis Sci, 2012, 57(2): 355-363. doi:  10.1007/s10620-011-1883-8
[25] JI W L, LIU W, HUO Y, et al. Banxia Xiexin Decoction ameliorates dextran sulfate sodium(DSS)-induced ulcerative colitis via inhibiting serine-threonine protein kinase(Akt)/mitogen-activated protein kinase(MAPK)signaling pathway[J]. Biotechnol Appl Biochem, 2023, 70(4): 1530-1542. doi:  10.1002/bab.2451
[26] MATSUMOTO K, URABE Y, OKA S, et al. Genomic landscape of early-stage colorectal neoplasia developing from the ulcerative colitis mucosa in the Japanese population[J]. Inflamm Bowel Dis, 2021, 27(5): 686-696. doi:  10.1093/ibd/izaa268
[27] FRIIS-OTTESSEN M, BURUM-AUENSEN E, SCHJØLBERG A R, et al. TP53/p53 alterations and Aurora A expression in progressor and non-progressor colectomies from patients with longstanding ulcerative colitis[J]. Int J Mol Med, 2015, 35(1): 24-30. doi:  10.3892/ijmm.2014.1974